Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

BackgroundInfrainguinal endovascular interventions can be the first-choice treatment for suitable patients with peripheral artery disease (PAD). However, the choice of anesthesia for infrainguinal endovascular procedures, particularly in emergency situations, remains underexplored. This study aimed to conduct a retrospective analysis based on a multi-institutional nationwide registry to compare the 30-day outcomes of patients with chronic limb-threatening ischemia (CLTI) who received either local anesthesia (LA) or general anesthesia (GA) during emergency infrainguinal endovascular interventions.MethodsPatients who underwent emergency infrainguinal endovascular revascularization for CLTI (tissue loss or rest pain) were selected from the ACS-NSQIP database from 2012-2022. Multivariable logistic regression was used to compare 30-day outcomes between patients under GA and LA, where demographics, baseline characteristics, and symptomatology were adjusted.ResultsAmong 703 patients, 292 (41.54%) were under LA, and 411 (58.46%) were under GA. Patients under LA had lower bleeding requiring transfusion (aOR = 0.428, 95 CI = 0.281-0.653, < 0.01), lower postoperative wound complications (aOR = 0.289, 95 CI = 0.137-0.612, < 0.01), and shorter operative time (102.00 ± 72.38 vs 150.70 ± 105.40 minutes, < 0.01). All other 30-day outcomes, including mortality, organ system complications, and limb-specific outcomes, were comparable between patients under LA and GA.ConclusionLA and GA can be considered equivalent options for eligible CLTI patients undergoing emergency infrainguinal endovascular revascularization, with close monitoring of wound and bleeding complications recommended for GA patients. Further studies are necessary to evaluate long-term outcomes in these patients.

Download full-text PDF

Source
http://dx.doi.org/10.1177/00031348251331295DOI Listing

Publication Analysis

Top Keywords

infrainguinal endovascular
20
30-day outcomes
16
emergency infrainguinal
16
endovascular revascularization
12
outcomes patients
12
patients
10
general anesthesia
8
patients chronic
8
chronic limb-threatening
8
limb-threatening ischemia
8

Similar Publications

BackgroundChronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), results in significant morbidity and mortality. The Global Limb Anatomic Staging System (GLASS) is a new tool designed to predict outcomes in CLTI patients undergoing endovascular treatments, yet its relationship with short-term outcomes requires further investigation.ObjectiveThis study evaluates the correlation between GLASS staging and short-term outcomes in CLTI patients treated with endovascular procedures for infrainguinal lesions.

View Article and Find Full Text PDF

Open revascularization for infrainguinal peripheral arterial disease in elderly patients: A scoping review.

Semin Vasc Surg

September 2025

Division of Vascular and Endovascular Surgery, Department of Surgery, Northwell Health, Manhasset, NY; Zucker School of Medicine at Hofstra, Hempstead, NY. Electronic address:

Peripheral arterial disease (PAD) is a prevalent and debilitating condition in elderly patients, often leading to critical limb threatening ischemia (CLTI) and major amputations. While endovascular interventions are usually preferred for their lower perioperative risk, open surgical revascularization should also be considered due to its durability and superior patency in complex disease patterns. Age alone does not determine suitability for surgery; rather, candidacy hinges on frailty, functional status, comorbidities, and anatomical considerations.

View Article and Find Full Text PDF

Introduction: Although smoking cessation has been shown to improve outcomes after lower extremity revascularization (LER), the impact of cessation duration has not been well defined. This study investigates the impact of two cessation durations on LER outcomes in patients with chronic limb-threatening ischemia (CLTI).

Methods: The Peripheral Vascular Intervention, Infrainguinal Bypass, and Suprainguinal Bypass modules of the Vascular Quality Initiative (VQI) were utilized to identify patients whose first recorded LER occurred between 2016-2024 for CLTI.

View Article and Find Full Text PDF

Background: Drug-coated devices are frequently used in coronary and peripheral interventions, but their effect on amputation risk in peripheral artery disease is unclear. We assessed whether drug-coated devices affect the rate of above-ankle amputation in patients with chronic limb-threatening ischaemia undergoing infrainguinal endovascular revascularisation.

Methods: The Swedish Drug-Elution Trial in Peripheral Arterial Disease 1 (SWEDEPAD 1) was a pragmatic, nationwide, multicentre, participant-masked, registry-based, randomised controlled trial at 22 Swedish centres.

View Article and Find Full Text PDF

Background: Drug-coated devices are widely used to reduce restenosis after lower limb revascularisation in patients with peripheral artery disease, but their effect on patient-centred outcomes remains unclear. We assessed the effect of paclitaxel-coated devices on clinically important outcomes in patients with intermittent claudication undergoing infrainguinal endovascular revascularisation.

Methods: The Swedish Drug-Elution Trial in Peripheral Arterial Disease 2 (SWEDEPAD 2) was a pragmatic, nationwide, multicentre, participant-masked, registry-based, randomised controlled trial conducted at 22 Swedish vascular centres.

View Article and Find Full Text PDF